Loading...

A Phase 1, Single-Dose, Open-Label, 2-Period Crossover Study to Evaluate the Food- Effect on the Pharmacokinetics and Safety of TAK-536CCB (TAK-536 40 mg/ amlodipine 5 mg) in Healthy Male Subjects - Vivli | NLM Dataset Catalog